Competence Centre TEDD
Education, R&D and networking platform promoting the application of 3D organotypic technologies for therapies development, with the core goal of replacing animal experimentation according to 3Rs (Replacement, Reduction and Refinement).
Join us for the Biointerfaces International Conference (BIC) 2024, at the FHNW School of Life Sciences in Muttenz, from August 20-23, 2024.
Building on a rich tradition of hosting the event in Zürich, the 2024 edition of the conference is headed to a new location in Muttenz, taking advantage of networking and technology strengths that Basel, Switzerland’s pharmaceutical capital, has to offer. The scientific excellence and diverse program that attendees appreciate will remain unchanged.
NEW TEDD Partners
CHEMIE BRUNSCHWIG AG Are you looking for high quality products in the fields of chemistry, life science and labware? Chemie Brunschwig is the right place, which will surely suit your requirements.
Due to our sustainable and long-standing proven network, we offer an extensive range of innovative products and services.
Prometheus Life Technologies AG, a spin-off from the University of Zurich, pioneers space-based manufacturing for high-quality force-free cellular 3D organoid growth originating from adult human mesenchymal stem cells (MSCs), enabling scalable, reliable, and robust production of natural autologous human tissue for advancing drug development, transplantation, precision medicine, and ethical alternatives to animal experiments.
TEDD Partnership Fee 2024
Yearly TEDD Partnership fee 2024 is CHF 500.
TEDD Partnership conditions:
- Two people from TEDD Partner organization can attend TEDD events free of charge. Subsequent people from this organization will receive a 50% discount for that event.
- TEDD Partnership period is from January to December of the given year.
- TEDD Partnership extends for the following year unless cancelled.
- TEDD Partner can cancel partnership latest on 30 November of the current year effective next year by sending us an email on info.tedd@zhaw.ch.
TEDD (Tissue Engineering for Drug Development and Substance Testing) is an education, R&D and networking platform promoting the application of 3D organotypic technologies, with the core goal of replacing animal experimentation for therapies development. Based in Switzerland, TEDD is one of its kind in Europe focused on 3D for 3Rs. The community is composed of international members from academia, clinics, industry and non-profits. Training of members is achieved through regular events at the national and international level, including workshops, symposia, company visits, scientific reviews and we provide a platform to generate research consortia, projects and grant applications.
This might also interest you
Partnership
Who are our Partners? What are the benefits of joining our network? How to become a Partner of CC TEDD?
About
Partnership
Team
Learn more about vision, goals, competencies and history of CC TEDD.
Who are our Partners? What are the benefits of joining our network? How to become a Partner of CC TEDD?
Meet the team and board of the Competence Centre.